Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")

NCT00955162 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Indivior Inc.